Home/Acticor Biotech/Jean-Louis Misset
JM

Jean-Louis Misset

Chairman of the Board

Acticor Biotech

Therapeutic Areas

Acticor Biotech Pipeline

DrugIndicationPhase
Glenzocimab (ACT017)Acute Ischemic StrokePhase 2/3